Specific Agent can Subsidize Celiac Disease
Notably, the approval of 9 Meters Biopharma's larazotide acetate, expected within the next several years, will mark the first CD-specific agent to enter the market. ‘Celiac disease (CD) represents an area of high unmet clinical need as…